Skip to content
Recall Observatory FDA recall evidence

Device product

Binding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (¿2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings.

Z-1301-2018

March 09, 2018

Class II

Product summary

Firm
The Binding Site Group, Ltd.
Event
Event 79499
Status
Terminated
Classification
Class II
Quantity
20 kits distributed to the U.S.
Official record key
device-enforcement:Z-1301-2018

Official wording

Reason: The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

Code information: Lot 407460, UDI 05051700017688

Distribution pattern: US Distribution was made to CA. There was no foreign/military/government distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.